1. Home
  2. BCDA vs CLWT Comparison

BCDA vs CLWT Comparison

Compare BCDA & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • CLWT
  • Stock Information
  • Founded
  • BCDA N/A
  • CLWT 1971
  • Country
  • BCDA United States
  • CLWT Hong Kong
  • Employees
  • BCDA N/A
  • CLWT N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • CLWT Professional and commerical equipment
  • Sector
  • BCDA Health Care
  • CLWT Consumer Discretionary
  • Exchange
  • BCDA Nasdaq
  • CLWT Nasdaq
  • Market Cap
  • BCDA 10.1M
  • CLWT 8.7M
  • IPO Year
  • BCDA N/A
  • CLWT 1997
  • Fundamental
  • Price
  • BCDA $2.35
  • CLWT $1.24
  • Analyst Decision
  • BCDA Strong Buy
  • CLWT
  • Analyst Count
  • BCDA 1
  • CLWT 0
  • Target Price
  • BCDA $25.00
  • CLWT N/A
  • AVG Volume (30 Days)
  • BCDA 238.1K
  • CLWT 13.1K
  • Earning Date
  • BCDA 08-12-2025
  • CLWT 04-30-2025
  • Dividend Yield
  • BCDA N/A
  • CLWT N/A
  • EPS Growth
  • BCDA N/A
  • CLWT N/A
  • EPS
  • BCDA N/A
  • CLWT 0.10
  • Revenue
  • BCDA $3,000.00
  • CLWT $15,383,000.00
  • Revenue This Year
  • BCDA N/A
  • CLWT N/A
  • Revenue Next Year
  • BCDA N/A
  • CLWT N/A
  • P/E Ratio
  • BCDA N/A
  • CLWT $13.03
  • Revenue Growth
  • BCDA N/A
  • CLWT N/A
  • 52 Week Low
  • BCDA $1.63
  • CLWT $1.01
  • 52 Week High
  • BCDA $4.66
  • CLWT $1.70
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 54.75
  • CLWT 57.94
  • Support Level
  • BCDA $2.22
  • CLWT $1.16
  • Resistance Level
  • BCDA $2.42
  • CLWT $1.30
  • Average True Range (ATR)
  • BCDA 0.13
  • CLWT 0.06
  • MACD
  • BCDA 0.01
  • CLWT 0.01
  • Stochastic Oscillator
  • BCDA 72.97
  • CLWT 62.68

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.

Share on Social Networks: